| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) | 
|---|
| 05/22/1990 | CA1269374A1 Diazepinones | 
| 05/22/1990 | CA1269373A1 Thieno-triazolo-1,4-diazepino-2-carboxylic acid amides | 
| 05/22/1990 | CA1269371A1 Polycyclic aromatic derivatives, and their use in cosmetics | 
| 05/22/1990 | CA1269370A1 Daunomycin and adriamycin sulfono and sulfoxo analogues | 
| 05/22/1990 | CA1269367A1 Sialosylcerebrosides and a preparation method thereof | 
| 05/22/1990 | CA1269364A1 Substituted penem derivatives and process for their preparation | 
| 05/22/1990 | CA1269331A1 Solid oral anticariogenic composition | 
| 05/22/1990 | CA1269328A1 Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same | 
| 05/22/1990 | CA1269327A1 Process for preventing or reversing cataract formation using protein modification reagents | 
| 05/21/1990 | CA2003537A1 Inhibitors for glycosaminosyl transferase v | 
| 05/21/1990 | CA2003408A1 Antiviral agents | 
| 05/21/1990 | CA2003397A1 2(1h)-quinolinone compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | 
| 05/21/1990 | CA2003395A1 Anti-atherosclerotic diaryl compounds | 
| 05/21/1990 | CA2003385A1 A method for enhancing the lowering of plasma cholesterol levels | 
| 05/19/1990 | CA2003306A1 Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimido(6,1-a)isoquinolin-4-one derivatives and their use | 
| 05/18/1990 | CA2003261A1 Process for preparing melanogenic inhibitor, and pigmentation-lightening agent containing the same | 
| 05/18/1990 | CA2003210A1 Anti-hyperendothelinemia agent | 
| 05/18/1990 | CA2003120A1 Isoxazolopyridine type mevalonolactones | 
| 05/18/1990 | CA2003091A1 Substituted oxadiaminobutanes | 
| 05/18/1990 | CA2002965A1 Conjugate of prostaglandin and polysaccharide | 
| 05/17/1990 | WO1990005139A1 14α,17α-ETHANO-ESTRATRIENES | 
| 05/17/1990 | WO1990005135A2 Process for the specific synthesis of new dithiocarbamic acid esters by substituting hydroxylated sites on mono- or polyhydroxylated molecules; products obtained by this process and their application | 
| 05/17/1990 | WO1990005133A1 Muscarinic receptor antagonists | 
| 05/17/1990 | WO1990005130A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs | 
| 05/17/1990 | WO1990004980A1 Drug composition | 
| 05/17/1990 | WO1990004973A1 Treatment of myelosuppression associated with acquired immune deficiency | 
| 05/17/1990 | WO1990004971A1 Improved viscoelastic fluid for use in surgery and other therapies and method of using same | 
| 05/17/1990 | WO1990004970A1 Antithrombotic composition | 
| 05/17/1990 | WO1990004968A1 Inhibition of human retroviruses | 
| 05/17/1990 | WO1990004967A2 Topical ointment | 
| 05/17/1990 | WO1990004966A2 Chemoprevention of electrophilic damage by mercaptopurine analogs | 
| 05/17/1990 | WO1990004965A1 Dosage form having reduced abuse potential | 
| 05/17/1990 | WO1990004964A1 Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine | 
| 05/17/1990 | WO1990004958A1 Anti-inflammatory active ingredients for cosmetic preparations | 
| 05/17/1990 | WO1990004917A1 Heterocyclic peptide renin inhibitors | 
| 05/17/1990 | WO1990003979A3 Anti-androgen compounds | 
| 05/17/1990 | WO1990003170A3 Prostaglandin-derivatives having antithrombotic activity | 
| 05/17/1990 | WO1990002802A3 Viral nucleotide sequences | 
| 05/17/1990 | WO1990001927A3 Use of paf antagonists for treating autoimmune diseases | 
| 05/17/1990 | WO1990001321A3 Method for treating and preventing loss of bone mass | 
| 05/17/1990 | DE3844655A1 Use of imexon as immunosuppressant | 
| 05/17/1990 | CA2002980A1 Agents for the treatment of acute and chronic obstructive respiratory passage diseases | 
| 05/17/1990 | CA2002888A1 Heterocyclic amides | 
| 05/17/1990 | CA2001159A1 7-oxadicycloheptane imino interphenyleneoxy substituted prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease | 
| 05/17/1990 | CA2001028A1 7-oxabicycloheptane imino interphenylene substituted prostaglandin analogs useful in the treatment of thrombotic disease | 
| 05/16/1990 | EP0368823A2 Biologically active lipoprotein and its use | 
| 05/16/1990 | EP0368758A2 Zinc cysteate, its preparation and its pharmaceutical and cosmetic uses | 
| 05/16/1990 | EP0368756A1 Dibenzocycloheptene derivatives, process for their preparation and their use as medicaments | 
| 05/16/1990 | EP0368719A2 Novel analogs of peptidase substrates | 
| 05/16/1990 | EP0368652A1 Imidazoquinoxalines and their preparation | 
| 05/16/1990 | EP0368645A2 Memory-enhancing compositions containing dioxopiperidine derivatives | 
| 05/16/1990 | EP0368640A2 Heterocyclic compounds | 
| 05/16/1990 | EP0368534A2 Prevention of anal leakage of polyorganosiloxane fluids used as fat substitutes in foods | 
| 05/16/1990 | EP0368464A1 Thiopene-2 carboxamide derivatives and their pharmaceutical use | 
| 05/16/1990 | EP0368410A2 Optically active benzoxazines and bezothiazines and a process for their stereospecific preparation | 
| 05/16/1990 | EP0368409A2 Compositions for the transdermal delivery of buprenorphine salts | 
| 05/16/1990 | EP0368406A2 Compositions for the transdermal delivery of pharmaceutical actives | 
| 05/16/1990 | EP0368388A2 3-Piperidinyl-1,2-benzisoxazoles | 
| 05/16/1990 | EP0368384A1 Thiazole derivatives | 
| 05/16/1990 | EP0368373A1 Multi-phase contraceptive preparation | 
| 05/16/1990 | EP0368349A2 Serine analogs of BU-3608 antibiotics | 
| 05/16/1990 | EP0368343A2 Ameliorating composition for dysmnesia | 
| 05/16/1990 | EP0368339A2 Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt | 
| 05/16/1990 | EP0368223A2 Use of ethylene diamine tetraacetic acid as inhibitor of calcium/calmoduline-dependent protein kinase II or protein kinase C | 
| 05/16/1990 | EP0368188A1 1,2,3,4-Tetrahydro-1,9-acridinediamines, a process for their preparation and their use as medicaments | 
| 05/16/1990 | EP0368175A1 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine. | 
| 05/16/1990 | EP0368160A1 Tetralin derivatives | 
| 05/16/1990 | EP0367974A1 Cis-complexes with a 1,3-diaminopropane derivative as a ligand, methods for their preparation and pharmaceutical agents containing such complexes | 
| 05/16/1990 | EP0367954A1 Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics | 
| 05/16/1990 | EP0367944A2 Ether derivative of 4-[3H] -quinazolinone, a process for the preparation thereof, and pharmaceutical compositions | 
| 05/16/1990 | EP0367895A1 Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them | 
| 05/16/1990 | EP0367888A1 2,2-Disubstituted 2,3-dihydro-1,4-benzodioxin derivatives having hypotensive activity | 
| 05/16/1990 | EP0305297B1 Derivatives of aza-z-bicyclooctane-caboxylicacid-3, processes for their preparation and pharmaceutical compositions containing them | 
| 05/16/1990 | EP0208755B1 Thromboxane antagonists in the treatment of hormone-dependent neoplasias | 
| 05/16/1990 | EP0173210B1 Pellet preparation | 
| 05/16/1990 | CN1042153A 3-aryloxymethyl-cephalosporin derivatives, their preparation and their medical use | 
| 05/16/1990 | CN1042152A Substituted thienopyrans as antihypertensive agents | 
| 05/16/1990 | CN1042151A Preparation for camptothecin arginine salt | 
| 05/16/1990 | CN1042148A Anti-anxiety agents | 
| 05/16/1990 | CN1042147A Thiochroman esters of phenols and terephthallates having retinoid-like activity | 
| 05/16/1990 | CN1042146A Branched-chain alkyl esters of 2-(4-(2-piperidiono-ethoxy)-benzoyl)-benzoic acid, processes for their preparation and their use as spasmolytic agents | 
| 05/16/1990 | CN1042145A Novel quinolyloxazole-2-ones useful as proteinkinase c inhibitors | 
| 05/16/1990 | CN1042076A Method for preparing anion exchange resin delivery system | 
| 05/16/1990 | CN1042075A Medicines for transcortical application containing steroidhormonen | 
| 05/16/1990 | CN1042074A Prescription for anti-pus ulser agent | 
| 05/16/1990 | CN1042071A Novel dosage form | 
| 05/16/1990 | CN1042045A Extruder for edible anion exchange resin delivery system | 
| 05/16/1990 | CN1007977B Process for the preparation of 7-amino-1-cyclopxopyl-6, 8-dihalogeno-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acids | 
| 05/16/1990 | CN1007959B Improves antiinfiammatory compositions and methods | 
| 05/16/1990 | CN1007958B Process for the preparation of metal complexes of bis-indole compounds and agueous pharmaceutical compositions containing them | 
| 05/16/1990 | CA2002814A1 Angiostatic agents | 
| 05/15/1990 | US4925979 Flavone carboxylic acid derivatives | 
| 05/15/1990 | US4925952 Process for preparing 1-hydroxyalkyl-5-nitroimidazoles | 
| 05/15/1990 | US4925950 Hydroxyalkylation | 
| 05/15/1990 | US4925932 Preparation of double sulfate salt of desoxyfructosyl serotonin and creatinine | 
| 05/15/1990 | US4925879 Antidepressants | 
| 05/15/1990 | US4925878 N-phenylisopropyl-n-methyl-propylvinylamines; oral administration | 
| 05/15/1990 | US4925877 Antitumor agents, bactericides, enzyme inhibitor | 
| 05/15/1990 | US4925874 Novel cyclopropane carboxylates | 
| 05/15/1990 | US4925873 Prostaglandin derivatives or substituted phenylacetic acids |